What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Catalysis
- Enzyme
His primary scientific interests are in NAMI-A, Ruthenium, Stereochemistry, Medicinal chemistry and Organic chemistry.
He has included themes like Cancer research, Antimetastatic Agent, Metastasis, Pathology and Cytotoxicity in his NAMI-A study.
His Ruthenium research is multidisciplinary, incorporating elements of Combinatorial chemistry and Dimethyl sulfoxide.
His Stereochemistry study incorporates themes from Sulfoxide, Macromolecule, Ligand and Crystal structure.
His research investigates the connection between Organic chemistry and topics such as Polymer chemistry that intersect with problems in Rhodium and Selective reduction.
In general Catalysis, his work in Palladium, Hydrogen transfer and Transition metal is often linked to Homogeneous linking many areas of study.
His most cited work include:
- Asymmetric hydrogen transfer reactions promoted by homogeneous transition metal catalysts (687 citations)
- Ruthenium Antimetastatic Agents (372 citations)
- cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X=Cl, Br): synthesis, structure, and antitumor activity (260 citations)
What are the main themes of his work throughout his whole career to date?
Giovanni Mestroni spends much of his time researching Medicinal chemistry, Catalysis, Organic chemistry, Ruthenium and Stereochemistry.
The concepts of his Medicinal chemistry study are interwoven with issues in Rhodium, Ligand, Cobalt, Molecule and Aryl.
His biological study spans a wide range of topics, including Phenanthroline and Polymer chemistry.
His studies deal with areas such as Sulfoxide, Cancer research, Cisplatin, Dimethyl sulfoxide and Lewis lung carcinoma as well as Ruthenium.
Giovanni Mestroni usually deals with Lewis lung carcinoma and limits it to topics linked to Pathology and NAMI-A.
His Stereochemistry research is multidisciplinary, relying on both Pyridine, Isomerization and Crystal structure.
He most often published in these fields:
- Medicinal chemistry (31.56%)
- Catalysis (28.00%)
- Organic chemistry (27.56%)
What were the highlights of his more recent work (between 1998-2015)?
- Ruthenium (23.56%)
- Polymer chemistry (20.00%)
- Palladium (10.67%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Ruthenium, Polymer chemistry, Palladium, Ligand and Polymerization.
The NAMI-A research he does as part of his general Ruthenium study is frequently linked to other disciplines of science, such as Nitrogen oxide, therefore creating a link between diverse domains of science.
His work deals with themes such as Nitric oxide and Nitrogen, which intersect with Polymer chemistry.
His study on Palladium also encompasses disciplines like
- Styrene which intersects with area such as Catalysis, Polyketone and Cationic polymerization,
- Counterion, Methylene and Moiety most often made with reference to Nuclear magnetic resonance spectroscopy.
His work carried out in the field of Ligand brings together such families of science as Inorganic chemistry and Medicinal chemistry.
His research in Medicinal chemistry intersects with topics in Aryl and Stereochemistry.
Between 1998 and 2015, his most popular works were:
- Ruthenium Antimetastatic Agents (372 citations)
- Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A (168 citations)
- In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. (130 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Catalysis
- Enzyme
Giovanni Mestroni mainly investigates NAMI-A, Ruthenium, Lewis lung carcinoma, Pathology and Stereochemistry.
His NAMI-A research integrates issues from Metastasis, Cisplatin and Cytotoxicity.
His studies in Ruthenium integrate themes in fields like Sulfoxide, Dimethyl sulfoxide and Combinatorial chemistry.
Giovanni Mestroni focuses mostly in the field of Sulfoxide, narrowing it down to topics relating to Derivative and, in certain cases, Medicinal chemistry.
His Lewis lung carcinoma study integrates concerns from other disciplines, such as Cell cycle and Cancer research.
His research combines Isomerization and Stereochemistry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
